Novartis joins the IMPRESS oncology study with six of its cancer medicines to treat up to one hundred patients.
Five new partners have joined CONNECT.
Eva S. Dugstad is our new research and industry facilitator aka competence broker for Oslo-based companies.
Office spaces have transformed into laboratories in Oslo Cancer Cluster Incubator.
ICCS 2021 highlighted success stories and promising newcomers in oncology innovation.
Oslo Cancer Cluster gathered the Norwegian oncology community for a mid-year update in June.